Unlocking New Possibilities: Dual Immune Blockade in Brain Metastases from Rare Tumors.
Where this comes from
- Record sourced from PubMed, PMID 41801052.
- Also identified by DOI 10.1158/1078-0432.CCR-25-4816.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The results of a recent trial undoubtedly contribute a vital element to the overarching management of rare tumors and offer new treatment hopes for patients with brain metastases, thereby paving the way for future research in immunotherapy.